Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease
1 other identifier
observational
500
1 country
1
Brief Summary
Gastroesophageal reflux disease (GERD) is a common and important disorder. Previous studies have demonstrated the association of obesity with GERD, and now obesity is regarded as a risk factor for GERD. Moreover, body mass index (BMI), an indicator of general obesity, correlates with severity of symptoms and degree of erosive esophagitis. Waist circumference, an indicator of abdominal obesity, has stronger correlation with intra-abdominal pressure and low-grade inflammatory state when compared with BMI. Nevertheless the association of waist circumference with severity of GERD has not been studied. The primary aim of this study is to compare BMI with waist circumference for their independent association with severity of GERD. The secondary aim is to evaluate independent risk factors of severity of GERD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 13, 2008
CompletedFirst Posted
Study publicly available on registry
June 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedOctober 19, 2010
October 1, 2010
1.1 years
June 13, 2008
October 18, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the degree fo erosive esophagitis according to Los-Angels classification
on the day of endoscopy examination
Secondary Outcomes (1)
gastro-reflux severity score as evaluated by standardized questionnaire
at enrollment (before upper GI endoscopy)
Study Arms (3)
NERD
patients with typical gastro-reflux symptoms but no erosions were discernible on upper gastrointestinal endoscopy
EE
Patients with both typical gastroesophageal reflux symptoms and characteristic flam-like erosions as demonstrated on upper gastrointestinal endoscopy
FD
Patients report no typical reflux symptoms but fulfill diagnostic criteria of functional dyspepsia, whose upper gastrointestinal endoscopy are negative.
Interventions
All patients undergo anthropometric measurements to record body weight, body height and waist circumference on the day of enrollment
Eligibility Criteria
Outpatients at a general hospital with 1000 beds in north-eastern Taiwan
You may qualify if:
- age more than 20 years old and less than 70 years old
- typical gastroesophageal reflux symptoms (heart burn and acid reflux)
- outpatient
- complete upper gastrointestinal endoscopy
You may not qualify if:
- age less than 20 years or more than 70 years old
- receive medication for reflux disease (including proton pump inhibitor, histamine type 2 receptor blocker, prokinetic agents) in previous one month
- pregnant women
- history of abdominal surgery
- severe comorbidity with cirrhosis, end-stage renal disease, heart failure
- no written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lotung Poh-Ai Hospital
Lotung Town, Ilan County, 265, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yao-Chun Hsu, M.D.
Lotung Poh-Ai Hospital, Ilan, Taiwan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 13, 2008
First Posted
June 17, 2008
Study Start
June 1, 2008
Primary Completion
July 1, 2009
Study Completion
August 1, 2009
Last Updated
October 19, 2010
Record last verified: 2010-10